Overview Financials News + Filings Key Docs Charts Holdings Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Acq. announced
Quarterly results
Appointed director
|
|
Myrexis, Inc. (MYRX)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 03/31/2020 |
4/A
| COUCHMAN JONATHAN (10% Owner) has filed a Form 4 on ENZON PHARMACEUTICALS, INC.|
Txns:
| Bought 19,709 shares
@ $0.135, valued at
$2.7k
Bought 2,678 shares
@ $0.14, valued at
$374.9
Bought 469,551 shares
@ $0.14, valued at
$65.7k
Bought 160,785 shares
@ $0.14, valued at
$22.5k
|
|
| 09/14/2009 |
4/A
| Laslie W Wayne (COO) has filed a Form 4 on Myriad Pharmaceuticals, Inc. |
| 09/14/2009 |
4/A
| Form 4 - Statement of changes in beneficial ownership of securities [amend] |
| 09/14/2009 |
4/A
| LOLLINI ROBERT J (CFO) has filed a Form 4 on Myriad Pharmaceuticals, Inc. |
| 09/14/2009 |
4/A
| Form 4 - Statement of changes in beneficial ownership of securities [amend] |
| 09/14/2009 |
4/A
| Form 4 - Statement of changes in beneficial ownership of securities [amend] |
| 09/14/2009 |
4/A
| Form 4 - Statement of changes in beneficial ownership of securities [amend] |
|
|